IBD sgi Diagnostic IBD

Synonyms
Allscripts (AEHR) Order Name	IBD sgi Diagnostics
Sunrise Clinical Manager (SCM) Order Name	IBD sgi Diagnostic
EPIC Order Name	IBD sgi Diagnostic
Clinical Info	Must draw both a Lavender and Gold top tube for this assay Combines serologic, genetic, and inflammation markers to help differentiate IBD vs non-IBD and ulcerative colitis vs Crohn’s disease. This test aids healthcare providers in differentiating IBD vs non-IBD and CD vs UC in one comprehensive blood test. This assay includes 9 serological markers ASCA IgA, ASCA IgG and proprietary markers anti-Fla-X, anti-A4-Fla2, anti-CBir1, anti-OMPC, and DNAse-sensitive pANCA that helps identify patients with IBD and utilizes Smart Diagnostic Algorithm Technology to improve the predictive accuracy. Genetic susceptibility influences immune responses and this assay includes evaluation of ATG16L1, STAT3, NKX2-3, and ECM1. Inflammatory markers include VEGF, ICAM-1, VCAM-1, CRP, SAA. While most other labs only offer assay values, PROMETHEUS® IBD sgi Diagnostic® provides added clarity in diagnosing IBD, UC, and CD.
Specimen Type	Blood
Container	Requires both Lavender and Gold top Collection
Collection Instructions	Container/ Tube: Lavender (EDTA ) Top Tube and Gold Top Tube. Specimen: 2 mL serum and 2 mL EDTA whole blood Transport Temperature: Refrigerated Stability: 7 Days Room Temperature 30 Days Refrigerated
Transport Instructions	Refrigerated
Specimen Stability	7 Days Room Temperature 30 Days Refrigerated
Methodology	Enzyme-linked Immunosorbant Assay (ELISA) Indirect Immunofluorenscence Assay (IFA)
Days Performed
Performing Laboratory	Prometheus Therapeutics & Diagnostics Must draw both a Lavender and Gold top tube for this assay Test Code 1800
CPT	81405 83520 x 6 82397 x 4 86140 88346 81479 x 3 88350
PDM	5901354
Result Interpretation See Report
Forms